4-Bromo-3-(trifluoromethyl)pyridine is a reactant used in the preparation of GPR40 modulators in the treatment of metabolic diseases such as diabetes. Bub1 kinase inhibitors, controlling chromosomal stability and senescence, are also synthesized utilizing this reagent.
